An Overview on GPCRs and Drug Discovery: Structure-Based Drug Design and Structural Biology on GPCRs
Author:
Lundstrom Kenneth
Reference97 articles.
1. Blundel, T.L. (1996) Structure-based drug design. Nature 384S, 23–26. 2. Stoll, V., Qin, W., Stewart, K.D., Jakob, C., Park, C., Walter, K., Simmer, R.L., Helfrich, R., Bussiere, D., Kao, J., Kempf, D., Sham, H.L., and Norbeck, D.W. (2002) X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 protease. Bioorg. Med. Chem. 10, 2803–2806. 3. Varghese, J.N. (1999) Development of neuraminidase inhibitors as anti-influenza virus drugs. Drug Dev. Res. 46, 176–196. 4. http://www.mpibp-frankfurt.mpg.de/michel/public/memprotstruct.html 5. Civelli, O., Nothacker, H.P., Saito, Y., Wang, Z., Lin, S.H., and Reinsheid, R.K. (2001) Novel neurotransmitters as natural ligands of orphan G protein-coupled receptors. Trends Neurosci. 24, 230–237.
Cited by
111 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|